2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensiveDrugmakers plan to raise prices on over 250 medications in the U.S. at the start of 2025, with most increases under 10%.
Insider Today: Austin's genius housing fixThe soaring prices of weight-loss drugs in the US lead to significant consumer challenges compared to prices in other countries.
Novo Nordisk launches Wegovy in China with prices well below U.S.Wegovy launches in China at lower prices than the US, but patients must bear costs individually.
Wait, Why Is Novo Selling Weight Loss Drugs for So Cheap in China?Novo Nordisk's Wegovy drug now costs $193 in China, significantly lower than the $1,350 in the US, raising concerns over pharmaceutical pricing disparities.
Insider Today: Austin's genius housing fixThe soaring prices of weight-loss drugs in the US lead to significant consumer challenges compared to prices in other countries.
Novo Nordisk launches Wegovy in China with prices well below U.S.Wegovy launches in China at lower prices than the US, but patients must bear costs individually.
Wait, Why Is Novo Selling Weight Loss Drugs for So Cheap in China?Novo Nordisk's Wegovy drug now costs $193 in China, significantly lower than the $1,350 in the US, raising concerns over pharmaceutical pricing disparities.
SCOTUS denial ends saga of Shkreli's infamous 5,000% drug price schemeThe Supreme Court denied Shkreli's appeal, finalizing a ruling to return $64.6 million after illegal pricing of Daraprim.
A doctor shares how his patients are trying to afford weight-loss drugs - and what happens if they can'tThe high cost of weight-loss drugs severely limits patient access, pushing many toward unsafe alternatives.
Weight-loss drugs are life-changing - and expensive. Here's one woman's solution.Women like Tara Rothenhoefer find affordable access to weight-loss medication through telehealth, despite previously facing unaffordable prices of over $1,000 monthly.
A doctor shares how his patients are trying to afford weight-loss drugs - and what happens if they can'tThe high cost of weight-loss drugs severely limits patient access, pushing many toward unsafe alternatives.
Weight-loss drugs are life-changing - and expensive. Here's one woman's solution.Women like Tara Rothenhoefer find affordable access to weight-loss medication through telehealth, despite previously facing unaffordable prices of over $1,000 monthly.
How little Denmark got homegrown giant Novo Nordisk to lower Ozempic pricesPharmaceutical pricing conflicts raise challenges globally, as Denmark struggles to afford Novo Nordisk's drugs despite their local production.
Analysts say market forces will lower cost of obesity drugsCongressional pressure likely won't significantly affect the pricing of Novo Nordisk's drugs, Ozempic and Wegovy.
How little Denmark got homegrown giant Novo Nordisk to lower Ozempic pricesPharmaceutical pricing conflicts raise challenges globally, as Denmark struggles to afford Novo Nordisk's drugs despite their local production.
Analysts say market forces will lower cost of obesity drugsCongressional pressure likely won't significantly affect the pricing of Novo Nordisk's drugs, Ozempic and Wegovy.
Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vialsEli Lilly is introducing lower-cost single-use vials of Zepbound to meet demand and improve accessibility for weight-loss medications.
2026 Prices for Drugs That Are Subject to NegotiationsThe Biden administration has negotiated lower maximum prices for 10 common medications under Medicare.
Big Pharma Exploited Patent Laws to Keep Medicare Drug Prices High, Report FindsPharmaceutical companies exploit patent laws to keep medication prices high for patients despite public funding for drug development.
2026 Prices for Drugs That Are Subject to NegotiationsThe Biden administration has negotiated lower maximum prices for 10 common medications under Medicare.
Big Pharma Exploited Patent Laws to Keep Medicare Drug Prices High, Report FindsPharmaceutical companies exploit patent laws to keep medication prices high for patients despite public funding for drug development.